The risk of long-term cardiovascular illness and mortality reduces with losing weight for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to dramatically worse outcomes, according to new research published today in The Lancet Diabetes (and) Endocrinology.
A team of data science researchers at The Arnhold Institute for Global Health of the Icahn School of Medicine at Mount Sinai reached these conclusions by applying new, advanced machine learning ...
The risk of long-term cardiovascular illness and mortality reduces with losing weight for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to dramatically worse outcomes, according to new research published today in The Lancet Diabetes (and) Endocrinology.
A team of data science researchers at The Arnhold Institute for Global Health of the Icahn School of Medicine at Mount Sinai reached these conclusions by applying new, advanced machine learning ...